R. Perez‐Soler

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

Frank V. Fossella, J S Lee, Dongjun Shin et al. · Journal of Clinical Oncology · 1995 · 259 citations

Medicine, Oncology, Pharmacology +16

A phase II trial of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor OSI-774, following platinum-based chemotherapy, in patients (pts) with advanced-EGFR-expressing, non-small cell lung cancer (NSCLC)

R. Perez‐Soler · Medical Entomology and Zoology · 2001 · 192 citations

Medicine, Oncology, Pharmacology +17

Clinical features and results of management of superior vena cava syndrome secondary to lymphoma.

R. Perez‐Soler, Peter McLaughlin, W S Velasquez et al. · Journal of Clinical Oncology · 1984 · 88 citations

Medicine, Oncology, Chemotherapy +12

Liver involvement in multiple myeloma

R. Perez‐Soler, Rafael Esteban, Elena Allende et al. · American Journal of Hematology · 1985 · 73 citations

Medicine, Internal Medicine, Pathology +17

Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma

Bonnie S. Glisson, Jin S. Lee, Judy Palmer et al. · Cancer · 1998 · 15 citations

Medicine, Oncology, Pharmacology +15